Transenterix Inc (NYSEAMERICAN:TRXC) Short Interest Update

Transenterix Inc (NYSEAMERICAN:TRXC) was the recipient of a significant growth in short interest during the month of December. As of December 29th, there was short interest totalling 15,231,489 shares, a growth of 4.6% from the December 15th total of 14,554,764 shares. Currently, 10.4% of the shares of the company are sold short. Based on an average daily volume of 2,743,340 shares, the short-interest ratio is currently 5.6 days.

Shares of Transenterix (TRXC) traded down $0.06 on Wednesday, hitting $1.85. 2,591,733 shares of the stock traded hands, compared to its average volume of 2,230,058. Transenterix has a 1-year low of $0.45 and a 1-year high of $5.00. The stock has a market capitalization of $396.49, a P/E ratio of -2.98 and a beta of 2.02.

Transenterix (NYSEAMERICAN:TRXC) last announced its earnings results on Thursday, November 9th. The medical instruments supplier reported ($0.09) earnings per share for the quarter, meeting the Thomson Reuters’ consensus estimate of ($0.09). Transenterix had a negative net margin of 21,045.36% and a negative return on equity of 137.69%.

In other news, CFO Joseph P. Slattery sold 529,609 shares of the stock in a transaction on Thursday, November 16th. The shares were sold at an average price of $2.80, for a total value of $1,482,905.20. Following the completion of the sale, the chief financial officer now directly owns 440,974 shares of the company’s stock, valued at $1,234,727.20. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, CFO Joseph P. Slattery sold 333,000 shares of the stock in a transaction on Tuesday, November 14th. The stock was sold at an average price of $2.93, for a total transaction of $975,690.00. Following the completion of the sale, the chief financial officer now directly owns 440,974 shares of the company’s stock, valued at $1,292,053.82. The disclosure for this sale can be found here.

A hedge fund recently raised its stake in Transenterix stock. Ladenburg Thalmann Financial Services Inc. raised its holdings in shares of Transenterix Inc (NYSEAMERICAN:TRXC) by 87.8% during the third quarter, according to its most recent filing with the SEC. The firm owned 79,150 shares of the medical instruments supplier’s stock after purchasing an additional 37,000 shares during the period. Ladenburg Thalmann Financial Services Inc. owned 0.05% of Transenterix worth $113,000 at the end of the most recent reporting period.

A number of equities analysts recently weighed in on the stock. Ladenburg Thalmann Financial Services set a $5.00 target price on shares of Transenterix and gave the stock a “buy” rating in a research report on Friday, October 20th. Stifel Nicolaus increased their price objective on shares of Transenterix from $3.75 to $4.00 and gave the company a “buy” rating in a research report on Tuesday, October 31st. BTIG Research reiterated a “hold” rating on shares of Transenterix in a research report on Monday, December 18th. Finally, Zacks Investment Research lowered shares of Transenterix from a “hold” rating to a “sell” rating in a research report on Thursday, January 11th. One research analyst has rated the stock with a sell rating, two have assigned a hold rating and two have given a buy rating to the company. The stock has a consensus rating of “Hold” and a consensus target price of $2.61.

WARNING: “Transenterix Inc (NYSEAMERICAN:TRXC) Short Interest Update” was reported by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are viewing this news story on another publication, it was stolen and republished in violation of United States and international trademark and copyright legislation. The correct version of this news story can be viewed at https://www.dispatchtribunal.com/2018/01/17/transenterix-inc-trxc-sees-large-increase-in-short-interest.html.

About Transenterix

TransEnterix, Inc is a medical device company. The Company is focused on the development and commercialization of ALF-X Surgical Robotic System (the ALF-X System), and SurgiBot System. The Company’s ALF-X System is a multi-port robotic surgery system, which allows multiple robotic arms to control instruments and a camera.

Receive News & Ratings for Transenterix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Transenterix and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply